Fluid compartmental shifts with efficacious pioglitazone therapy in overweight monkeys: implications for peroxisome proliferator-activated receptor–γ agonist use in prediabetes
To access this article, please choose from the options below
PII: S0026-0495(10)00064-8
doi:10.1016/j.metabol.2010.02.010
© 2010 Elsevier Inc. All rights reserved.
